[
    [
        {
            "time": "2021-05-17",
            "original_text": "康泰生物新冠疫苗纳入紧急使用！康泰生物的未来怎样看？",
            "features": {
                "keywords": [
                    "康泰生物",
                    "新冠疫苗",
                    "紧急使用"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "康泰生物新冠疫苗纳入紧急使用！康泰生物的未来怎样看？",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-05-17",
            "original_text": "该公司的一些股东和高管也在减持套现。上述的这些情况也值得投资者关注。",
            "features": {
                "keywords": [
                    "减持",
                    "股东",
                    "高管"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "该公司的一些股东和高管也在减持套现。上述的这些情况也值得投资者关注。",
                "Correlation": 7,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-05-17",
            "original_text": "康泰生物(300601)公司点评：新冠灭活疫苗纳入紧急使用 有望带来业绩弹性",
            "features": {
                "keywords": [
                    "康泰生物",
                    "新冠灭活疫苗",
                    "紧急使用",
                    "业绩弹性"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "康泰生物(300601)公司点评：新冠灭活疫苗纳入紧急使用 有望带来业绩弹性",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-05-17",
            "original_text": "中国又一款新冠疫苗获批使用丨医麦猛爆料",
            "features": {
                "keywords": [
                    "新冠疫苗",
                    "获批使用",
                    "医麦猛爆料"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "中国又一款新冠疫苗获批使用丨医麦猛爆料",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-05-17",
            "original_text": "国内新冠疫苗供不应求状况改变，康泰生物获批紧急使用，2021年其有望将完成蜕变",
            "features": {
                "keywords": [
                    "新冠疫苗",
                    "供不应求",
                    "康泰生物",
                    "紧急使用"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "国内新冠疫苗供不应求状况改变，康泰生物获批紧急使用，2021年其有望将完成蜕变",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-05-17",
            "original_text": "国产第六款新冠疫苗获批紧急使用",
            "features": {
                "keywords": [
                    "国产",
                    "新冠疫苗",
                    "紧急使用"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "国产第六款新冠疫苗获批紧急使用",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-05-17",
            "original_text": "东莞证券：康泰生物（300601.SZ）新冠疫苗被纳入紧急使用，维持“谨慎推荐”评级",
            "features": {
                "keywords": [
                    "东莞证券",
                    "康泰生物",
                    "新冠疫苗",
                    "紧急使用",
                    "谨慎推荐"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "东莞证券：康泰生物（300601.SZ）新冠疫苗被纳入紧急使用，维持“谨慎推荐”评级",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-05-17",
            "original_text": "东吴证券维持康泰生物买入评级：灭活新冠疫苗获得紧急使用，近期有望兑现较大业绩",
            "features": {
                "keywords": [
                    "东吴证券",
                    "康泰生物",
                    "灭活新冠疫苗",
                    "紧急使用",
                    "买入评级"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "东吴证券维持康泰生物买入评级：灭活新冠疫苗获得紧急使用，近期有望兑现较大业绩",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 10
            }
        }
    ]
]